Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Panova (Moscow, Russian Federation), V. Testov (Moscow, Russian Federation), G. Kaminskiy (Moscow, Russian Federation), A. Samoilova (Moscow, Russian Federation), E. Veselova (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation). Burden of the primary drug resistance of Mycobacterium tuberculosis in HIV-positive patients. 2996

Member's Comments

No comment yet.

Related content which might interest you: Primary drug resistance of mycobacterium tuberculosis in HIV-positive patients Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Primary drug resistance against mycobacterium tuberculosis in a high burden country Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006 Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients Source: Eur Respir J, 55 (6) 1902383; 10.1183/13993003.02383-2019 Year: 2020 Mycobacterium tuberculosis resistance profiles in index and secondary TB cases from the same household Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018 Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004 The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Structure of drug resistance of M. tuberculosis in children and adolescents with pulmonary TB Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002 Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan Source: International Congress 2019 – Drug-resistant tuberculosis Year: 2019 Transmission of Mycobacterium tuberculosis to households of tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 197s Year: 2005 Mycobacterium tuberculosis drug resistance surveillance in Belarus Source: Eur Respir J 2005; 26: Suppl. 49, 199s Year: 2005 Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Considerations upon the drug resistance spectrum of Mycobacterium tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 313s Year: 2001 Evaluation of the multidrug resistant TB in children with HIV infection Source: Eur Respir J 2004; 24: Suppl. 48, 439s Year: 2004 Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 Mdr tuberculosis and nontuberculous mycobacterium associated with HIV/AIDS in children Source: Annual Congress 2009 - Paediatric respiratory epidemiology: respiratory infections and rare diseases Year: 2009 Pulmonary tuberculosis among elderly and senile-aged patients depending on Mycobacterium strains Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017